Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.
That interview will encourage the shorts if anything. I was very disappointed . There was no actual information at all. Just told us what we know and failed to give remotest detail on how it will be paid for . And please how many times have I heard the old we hold shares so don’t want to dilute line, despite them going ahead in past . Sorry everyone this is not good enough. , no plan was in place if this drill failed, that’s obvious
I’m out. You can’t keep money in a company whose shares go from 16 to 11 in minutes Then up again. It’s sign that there is far more serious trouble than we as mere pi s. are aware of. Everything g pints to serenity bring worth more than mc but something’s not right
And how many I 3 e shares are in pi hands ? And how many of those read this and how many Who do read it take any notice . Not enough to make any major influence at all . Sorry it just doesn’t add up. Especially when every one contradicts every one else on here . It may influence some idiots who belive anything in the internet but they generally don’t hold many shares
Oh for gods sake stop arguing about rampers and derampers. Just ignore the post if you don’t like what it says . What’s said in here doesn’t influence price much. Pis only own 25% of coMpany and probably only 25% of them read all this crap
Boom Yes it could that’s whole point of it BUT it’s not going to turn 20ft of oil into 80ft . But it will give us all a much clearer of viability of the find . I suspect it will be positive but not overwhelmingly so . Therefore we will see what next drill brings
Good news fir nfx. If high prices are ok it’s more about finding way to pay the high cost. Drug pricing will continue to be a front-page issue; at the same time, pharmaceutical innovation will also dominate headlines. We are entering a phase where drug prices will continue to draw negative attention, but that attention will be balanced by the breathtaking innovation coming from biotechnology and pharmaceutical companies. When I was a medical student, cystic fibrosis would lead to certain death for patients in their 20s or 30s—even with intensive management. Today, a series of drugs from Vertex Pharmaceuticals—yes, expensive drugs—has transformed cystic fibrosis from a fatal disease into a chronic disease. As these breakthroughs like these multiply, expect the national dialog to shift focus from the high cost of drugs to finding new and different ways to pay for them in order to expand access to the most innovative products.
Well fact there a huge buys coMing I’m above 20p and up to 26p. Suggests it’s not a leak as it would just drift down or stay put. We have another drill too so value in that too , But god knows what going on with this share today. Longer we get no rns the better in my opinion
Hilarious.